Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
TIL Instil Bio Inc
- Stocks
- Healthcare
- NASDAQ: TIL
Price (delayed)
$34.4
Market cap
$225.66M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$11.97
Enterprise value
$293.61M
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer.
Highlights
Instil Bio's quick ratio has increased by 7% YoY
TIL's net income is up by 37% YoY but it is down by 5% QoQ
TIL's EPS is up by 37% year-on-year but it is down by 5% since the previous quarter
The company's equity fell by 30% YoY and by 14% QoQ
Key stats
What are the main financial stats of TIL
Market
Valuations
Earnings
Shares outstanding
6.56M
Market cap
$225.66M
Enterprise value
$293.61M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.55
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$80.15M
Net income
-$78.03M
EBIT
-$69.93M
EBITDA
-$66.49M
Free cash flow
-$45.5M
Per share
Balance sheet
Liquidity
EPS
-$11.97
EPS diluted
-$11.97
Free cash flow per share
-$6.96
Book value per share
$22.21
Revenue per share
$0
TBVPS
$36.35
Total assets
$237.45M
Total liabilities
$92.54M
Debt
$84.28M
Equity
$144.91M
Working capital
$212.04M
Debt to equity
0.58
Current ratio
30.33
Quick ratio
14.47
Net debt/EBITDA
-1.02
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-29.2%
Return on equity
-45.5%
Return on invested capital
-21%
Return on capital employed
-30.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TIL stock price
How has the Instil Bio stock price performed over time
Intraday
15.05%
1 week
28.6%
1 month
137.57%
1 year
222.7%
YTD
80.2%
QTD
98.16%
Financial performance
How have Instil Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$80.15M
Net income
-$78.03M
Gross margin
N/A
Net margin
N/A
TIL's net income is up by 37% YoY but it is down by 5% QoQ
The operating income has grown by 36% YoY but it has contracted by 9% from the previous quarter
Price vs fundamentals
How does TIL's price correlate with its fundamentals
Growth
What is Instil Bio's growth rate over time
Valuation
What is Instil Bio stock price valuation
P/E
N/A
P/B
1.55
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
TIL's EPS is up by 37% year-on-year but it is down by 5% since the previous quarter
TIL's price to book (P/B) is 41% higher than its last 4 quarters average of 1.1 but 3.1% lower than its 5-year quarterly average of 1.6
The company's equity fell by 30% YoY and by 14% QoQ
Efficiency
How efficient is Instil Bio business performance
TIL's ROIC is up by 27% year-on-year but it is down by 13% since the previous quarter
Instil Bio's return on assets has increased by 18% YoY but it has decreased by 12% QoQ
The return on equity has declined by 15% since the previous quarter but it rose by 11% year-on-year
Dividends
What is TIL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TIL.
Financial health
How did Instil Bio financials performed over time
TIL's total assets is 157% greater than its total liabilities
Instil Bio's current ratio has surged by 114% YoY and by 92% QoQ
TIL's total assets is down by 22% year-on-year and by 10% since the previous quarter
Instil Bio's debt is 42% less than its equity
The debt to equity has grown by 41% YoY and by 16% from the previous quarter
The company's equity fell by 30% YoY and by 14% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.